logo
Select company
Select metric
11.55%Gross Profits to Assets
VS
Market
42
Sector
52
Industry
73
History
89
$ 2.37Close
$ 1.1 - $ 6.45 52-Week Range
Ticker Information

Ticker

CCCC

Company Name

C4 THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

C4 THERAPEUTICS INC - Gross Profits to Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CCCC - GPA Historical data
DateTotal AssetsGross ProfitGross Profits to Assets
6/30/2025$ 296.53M$ 34.24M11.55%
3/31/2025$ 319.52M$ 39.78M12.45%
12/31/2024$ 349.6M$ 35.58M10.18%
9/30/2024$ 376.06M$ 33.67M8.95%
6/30/2024$ 381.09M$ 29.38M7.71%
3/31/2024$ 398.37M$ 20.04M5.03%
12/31/2023$ 376.45M$ 20.76M5.51%
9/30/2023$ 333.01M$ 20.35M6.11%
6/30/2023$ 375.01M$ 16.03M4.27%
3/31/2023$ 396.04M$ 27.2M6.87%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • C4 THERAPEUTICS INC's latest trailing twelve months (TTM) GPA stands at 0%.
  • Over the past 5 years, C4 THERAPEUTICS INC's average GPA has been 8.1%.
  • The median GPA for C4 THERAPEUTICS INC during this period was 8%
  • C4 THERAPEUTICS INC reached its highest GPA over the past 5 years at 12.45%.
  • The lowest GPA recorded by C4 THERAPEUTICS INC in the same timeframe 4.27%

C4 THERAPEUTICS INC's GPA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

GPA Benchmarks
CompanyGPA
VYGR : VOYAGER THERAPEUTICS INC 9.6%EDIT : EDITAS MEDICINE INC 18.47%FENC : FENNEC PHARMACEUTICALS INC 66.71%OABI : OMNIAB INC 7.7%MGX : METAGENOMI INC 12.4%TLSI : TRISALUS LIFE SCIENCES INC 73.75%SPRO : SPERO THERAPEUTICS INC 78.2%CELU : CELULARITY INC 20.43%UTMD : UTAH MEDICAL PRODUCTS INC 18.43%IVVD : INVIVYD INC 48.42%

Definition of Gross Profits to Assets

[Calculation] Gross Profits to Assets (GPA) measures how effective a company leverages its assets to generate gross profits. It is calculated as gross profits [GP] divided by [Assets].
GP / Assets
(=) GPA
GPA for C4 THERAPEUTICS INC is calculated as follows: GP [ $ 0 ] / Assets [ $ 229.13M ]
(=) GPA [ 0% ]

CCCC - Gross Profits to Assets, Last 5 years

4.27%

Minimum

Jun 30, 2023

12.45%

Maximum

Mar 31, 2025

8.1%

Average

8%

Median

GPA Benchmark Analysis

The chart above depicts the distribution of GPA for companies in the Total Stock Market. The average GPA of the companies is 20.16% with a standard deviation of 19.95%.
The following table provides additional summary stats:
GPA in the Market:
filtered constituents4.13K
min-50.32%
max83.98%
average20.16%
median15.35%
std19.95%